Literature DB >> 27241710

Levodopa impairs probabilistic reversal learning in healthy young adults.

Andrew Vo1,2, Ken N Seergobin1, Sarah A Morrow3, Penny A MacDonald4,5,6.   

Abstract

RATIONALE: Dopaminergic therapy improves some cognitive functions and worsens others in patients with Parkinson's disease (PD). These paradoxical effects are explained by the dopamine overdose hypothesis, which proposes that effects of dopaminergic therapy on a cognitive function is determined by the baseline dopamine levels in brain regions mediating that function.
OBJECTIVES: We directly tested this prevalent hypothesis, evaluating the effects of levodopa on stimulus-reward learning in healthy young adults, who presumably have optimal baseline dopamine levels and dopamine regulation.
METHODS: Twenty-six healthy, young adults completed a probabilistic reversal learning task in a randomized, double-blind, placebo-controlled, crossover design. Participants completed one session on levodopa 100 mg/carbidopa 25 mg and another session on placebo.
RESULTS: We found that levodopa impaired reversal learning relative to placebo. Further analyses revealed that levodopa impaired learning from both punishment and reward.
CONCLUSIONS: Exogenous dopamine impairs stimulus-reward learning, independent of PD pathology and prior to sensitization through repeated exposure, in healthy adults with normal cognition and baseline dopamine function. Our findings support the dopamine overdose hypothesis and caution clinicians about detrimental effects of levodopa in all clinical populations (e.g., early PD, restless leg syndrome) regardless of baseline cognitive and dopaminergic system function.

Entities:  

Keywords:  Cognition; Dopamine; Learning; Levodopa; Parkinson’s disease; Punishment; Reward; Striatum

Mesh:

Substances:

Year:  2016        PMID: 27241710     DOI: 10.1007/s00213-016-4322-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

1.  Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.

Authors:  Alex A MacDonald; Oury Monchi; Ken N Seergobin; Hooman Ganjavi; Ruzbeh Tamjeedi; Penny A MacDonald
Journal:  Mov Disord       Date:  2012-11-19       Impact factor: 10.338

2.  Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

Authors:  M A Mehta; R Swainson; A D Ogilvie; J Sahakian; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2001-09-11       Impact factor: 4.530

3.  A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

Authors:  Michael J Frank; Randall C O'Reilly
Journal:  Behav Neurosci       Date:  2006-06       Impact factor: 1.912

4.  The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.

Authors:  Penny A MacDonald; Alex A MacDonald; Ken N Seergobin; Ruzbeh Tamjeedi; Hooman Ganjavi; Jean-Sebastien Provost; Oury Monchi
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

5.  Levodopa: faster and better word learning in normal humans.

Authors:  Stefan Knecht; Caterina Breitenstein; Stefan Bushuven; Stefanie Wailke; Sandra Kamping; Agnes Flöel; Pienie Zwitserlood; E Bernd Ringelstein
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

6.  Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.

Authors:  Nikoletta Bódi; Szabolcs Kéri; Helga Nagy; Ahmed Moustafa; Catherine E Myers; Nathaniel Daw; György Dibó; Annamária Takáts; Dániel Bereczki; Mark A Gluck
Journal:  Brain       Date:  2009-05-04       Impact factor: 13.501

7.  Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning.

Authors:  Marieke E van der Schaaf; Martine R van Schouwenburg; Dirk E M Geurts; Arnt F A Schellekens; Jan K Buitelaar; Robbert Jan Verkes; Roshan Cools
Journal:  Cereb Cortex       Date:  2012-11-25       Impact factor: 5.357

8.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06

9.  Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson's disease.

Authors:  Moonsang Seo; Mazda Beigi; Marjan Jahanshahi; Bruno B Averbeck
Journal:  Front Syst Neurosci       Date:  2010-08-12

10.  L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

Authors:  Roshan Cools; Simon J G Lewis; Luke Clark; Roger A Barker; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2006-07-12       Impact factor: 7.853

View more
  10 in total

1.  The effect of dopamine on conditioned placebo analgesia in healthy individuals: a double-blind randomized trial.

Authors:  Matthias Zunhammer; Magnus Gerardi; Ulrike Bingel
Journal:  Psychopharmacology (Berl)       Date:  2018-06-25       Impact factor: 4.530

2.  Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk.

Authors:  Nicole R Karcher; Jessica P Y Hua; John G Kerns
Journal:  Neuropsychopharmacology       Date:  2019-07-04       Impact factor: 7.853

3.  Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults.

Authors:  Haley Gallant; Andrew Vo; Ken N Seergobin; Penny A MacDonald
Journal:  Front Neurosci       Date:  2016-08-19       Impact factor: 4.677

4.  Dopamine D2 receptor and β-arrestin 2 mediate Amyloid-β elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cells.

Authors:  Jing Lu; Xiaohang Li; Qinying Wang; Gang Pei
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

5.  Levodopa does not affect expression of reinforcement learning in older adults.

Authors:  J P Grogan; H K Isotalus; A Howat; N Irigoras Izagirre; L E Knight; E J Coulthard
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

6.  Phasic Dopamine Changes and Hebbian Mechanisms during Probabilistic Reversal Learning in Striatal Circuits: A Computational Study.

Authors:  Miriam Schirru; Florence Véronneau-Veilleux; Fahima Nekka; Mauro Ursino
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

Review 7.  Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults.

Authors:  Heather E Webber; Paula Lopez-Gamundi; Sydney N Stamatovich; Harriet de Wit; Margaret C Wardle
Journal:  Neurosci Biobehav Rev       Date:  2020-11-14       Impact factor: 8.989

8.  White noise enhances new-word learning in healthy adults.

Authors:  Anthony J Angwin; Wayne J Wilson; Wendy L Arnott; Annabelle Signorini; Robert J Barry; David A Copland
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

9.  Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.

Authors:  Cornelius J H M Klemann; Helena Xicoy; Geert Poelmans; Bas R Bloem; Gerard J M Martens; Jasper E Visser
Journal:  Mol Neurobiol       Date:  2017-10-10       Impact factor: 5.590

10.  SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease.

Authors:  Brian D Robertson; Abdullah S Al Jaja; Alex A MacDonald; Nole M Hiebert; Ruzbeh Tamjeedi; Ken N Seergobin; Ute I Schwarz; Richard B Kim; Penny A MacDonald
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.